Year |
Citation |
Score |
2021 |
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, ... ... Arias E, et al. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy. 1-382. PMID 33634751 DOI: 10.1080/15548627.2020.1797280 |
0.435 |
|
2006 |
Arias E, Gallego-Sandin S, del Barrio L, Villarroya M, Garcia AG, López MG. P4-295: Neuroprotective effects of acetylcholinesterase inhibitors Alzheimer's & Dementia. 2: S603-S604. DOI: 10.1016/J.Jalz.2006.05.2034 |
0.497 |
|
2005 |
Gallego-SandÃn S, Novalbos J, Rosado A, Cano-Abad MF, Arias E, Abad-Santos F, GarcÃa AG. Albumin prevents mitochondrial depolarization and apoptosis elicited by endoplasmic reticulum calcium depletion of neuroblastoma cells. European Journal of Pharmacology. 520: 1-11. PMID 16153637 DOI: 10.1016/J.Ejphar.2005.06.044 |
0.313 |
|
2005 |
Arias E, Gallego-SandÃn S, Villarroya M, GarcÃa AG, López MG. Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5Y neuroblastoma cells: role of nicotinic receptors. The Journal of Pharmacology and Experimental Therapeutics. 315: 1346-53. PMID 16144975 DOI: 10.1124/Jpet.105.090365 |
0.347 |
|
2004 |
Orozco C, de Los Rios C, Arias E, León R, GarcÃa AG, Marco JL, Villarroya M, López MG. ITH4012 (ethyl 5-amino-6,7,8,9-tetrahydro-2-methyl-4-phenylbenzol[1,8]naphthyridine-3-carboxylate), a novel acetylcholinesterase inhibitor with "calcium promotor" and neuroprotective properties. The Journal of Pharmacology and Experimental Therapeutics. 310: 987-94. PMID 15111641 DOI: 10.1124/Jpet.104.068189 |
0.319 |
|
2004 |
Arias E, Alés E, Gabilan NH, Cano-Abad MF, Villarroya M, GarcÃa AG, López MG. Galantamine prevents apoptosis induced by beta-amyloid and thapsigargin: involvement of nicotinic acetylcholine receptors. Neuropharmacology. 46: 103-14. PMID 14654102 DOI: 10.1016/S0028-3908(03)00317-4 |
0.336 |
|
Show low-probability matches. |